Skip to main content

Table 1 Comparison of the in vitro activities of selected antimicrobial agents tested against Escherichia coli (563 strains)

From: Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005–2010

Antimicrobial agent

MIC50

MIC90

Range

% susceptible/resistanta

 Cefuroxime

8

>16

≤2 – >16

55.2 / 43.2

 Cefoxitin

4

>16

≤4 – >16

74.9 / 13.7

 Ceftriaxone

≤0.25

>32

≤0.25 – >32

56.8 / 41.7

 Ceftazidime

≤1

>16

≤1 – >16

61.6 / 33.2

 Cefepime

0.25

>16

≤0.12 – >16

71.4 / 19.9

 Piperacillin/tazobactam 

4

32

≤0.5 – >64

83.1 / 3.9

 Imipenem

≤0.12

0.25

≤0.12 – 1

100.0 / 0.0

 Meropenem

≤0.12

≤0.12

≤0.12 – 0.5

100.0 / 0.0

 Ciprofloxacin

>4

>4

≤0.03 – >4

41.7 / 57.9

 Levofloxacin

>4

>4

≤0.5 – >4

41.7 / 56.7

 Gentamicin

≤2

>8

≤2 – >8

67.1 / 31.9

 Amikacin

≤4

8

≤4 – >32

95.7 / 0.4

 PolymyxinBb

≤0.5

≤0.5

≤0.5 – 1

100 / 0.0

 Colistinb

≤0.5

≤0.5

≤0.5 – 2

99.8 / 0.2

  1. a Criteria as published by the CLSI [16].
  2. bPseudomonas aeruginosa breakpoints.